{
    "id": "21985d1b-08dc-46d3-b8ed-ef43c96a88cd",
    "indications": {
        "text": "efavirenz combination antiretroviral agents indicated treatment human immunodeficiency virus type 1 ( hiv-1 ) infection adults pediatric patients least 3 months old weighing least 3.5 kg .",
        "doid_entities": [],
        "orphanet_entities": [
            {
                "disease": "immunodeficiency",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_101997"
            }
        ]
    },
    "contraindications": {
        "text": "efavirenz tablets usp taken orally daily empty stomach , preferably bedtime . ( 2 ) recommended adult dose : 600 mg. ( 2.2 ) voriconazole , increase voriconazole maintenance dose 400 mg every 12 hours decrease efavirenz dose 300 mg daily using capsule formulation . ( 2.2 ) rifampin , increase efavirenz dose 800 mg daily patients weighing 50 kg . ( 2.2 ) pediatric dosing based weight . ( 2.3 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "adverseReactions": "efavirenz contraindicated patients previously demonstrated clinically significant hypersensitivity ( e.g . , stevens-johnson syndrome , erythema multiforme , toxic skin eruptions ) components product . coadministration efavirenz elbasvir grazoprevir contraindicated [ ( 5.1 ) ( 7.1 ) ] .",
    "ingredients": [
        {
            "name": "EFAVIRENZ",
            "code": "JE6H2O27P8",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_119486"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (90000 WAMW)",
            "code": "UKE75GEA7F",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00840"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "organization": "Strides Pharma Science Limited",
    "name": "Efavirenz",
    "effectiveTime": "20231213",
    "indications_original": "Efavirenz in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg.",
    "contraindications_original": "Efavirenz tablets USP should be taken orally once daily on an empty stomach, preferably at bedtime. (2) Recommended adult dose: 600 mg. (2.2) With voriconazole, increase voriconazole maintenance dose to 400 mg every 12 hours and decrease efavirenz dose to 300 mg once daily using the capsule formulation. (2.2) With rifampin, increase Efavirenz dose to 800 mg once daily for patients weighing 50 kg or more. (2.2) Pediatric dosing is based on weight. (2.3)",
    "adverseReactions_original": "Efavirenz is contraindicated in patients with previously      demonstrated clinically significant hypersensitivity (e.g., Stevens-Johnson      syndrome, erythema multiforme, or toxic skin eruptions) to\u00a0\u00a0\u00a0\u00a0\u00a0 any of the      components of this product.\n                     Coadministration of efavirenz with      elbasvir and grazoprevir is contraindicated [see Warnings and      Precautions (5.1) and Drug Interactions (7.1)].",
    "drug": [
        {
            "name": "Efavirenz",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_119486"
        }
    ]
}